Brain‐Wide Neuroregenerative Gene Therapy Improves Cognition in a Mouse Model of Alzheimer's Disease
Advanced Science · 2025-04 · 12 (14)
DOI: 10.1002/advs.202410080 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 14.02.2025. Verfasst von Zheng Wu und 10 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Bioactive Molecules and Druggability Assessment, Guangdong Basic Research Center of Excellence for Natural Bioactive Molecule…. Hauptthemen laut MEDLINE: Alzheimer Disease, Genetic Therapy, Brain, Cognition. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key Technologies Research and Development Program of Guangzhou Municipality, Guangdong Provincial Introduction of Innovative Research and Development Team, Natural Science Foundation of Guangdong Province.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer's disease (AD) is a progressive and irreversible brain disorder with extensive neuronal loss in the neocortex and hippocampus. Current therapeutic interventions focus on the early stage of AD but lack effective treatment for the late stage of AD, largely due to the inability to replenish the lost neurons and repair the broken neural circuits. In this study, by using engineered adeno‐associated virus vectors that efficiently cross the blood–brain‐barrier in the mouse brain, a brain‐wide neuroregenerative gene therapy is developed to directly convert endogenous astrocytes into functional neurons in a mouse model of AD. It is found that ≈500 000 new neurons are regenerated and widely distributed in the cerebral cortex and hippocampus. Importantly, it is demonstrated that the converted neurons can integrate into pre‐existing neural networks and improve various cognitive performances in AD mice. Chemogenetic inhibition of the converted neurons abolishes memory enhancement in AD mice, suggesting a pivotal role for the newly converted neurons in cognitive restoration. Together, brain‐wide neuroregenerative gene therapy may provide a viable strategy for the treatment of AD and other brain disorders associated with massive neuronal loss.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Bioactive Molecules and Druggability Assessment, Guangdong Basic Research Center of Excellence for Natural Bioactive Molecules and Discovery of Innovative Drugs, Key Laboratory of CNS Regeneratio…
- Department of Biology, Huck Institutes of Life Sciences, Pennsylvania State University, University Park, PA, 16802, USA.
ORCID-Profile: Zheng Wu
Förderung
- Key Technologies Research and Development Program of Guangzhou Municipality
- Guangdong Provincial Introduction of Innovative Research and Development Team
- Natural Science Foundation of Guangdong Province
Zitieren
APA
Wu, Z., Xu, L., Xie, Y., Sambangi, A., Swaminathan, S., Pei, Z., Ji, W., Li, Z., Guo, Y., Li, Z., & Chen, G. (2025). Brain‐Wide Neuroregenerative Gene Therapy Improves Cognition in a Mouse Model of Alzheimer's Disease. Advanced Science, 12(14). https://doi.org/10.1002/advs.202410080
Vancouver
Wu Z, Xu L, Xie Y, Sambangi A, Swaminathan S, Pei Z, et al. Brain‐Wide Neuroregenerative Gene Therapy Improves Cognition in a Mouse Model of Alzheimer's Disease. Advanced Science. 2025;12(14). doi:10.1002/advs.202410080
BibTeX
@article{Wu2025,
author = {Wu, Zheng and Xu, Liang and Xie, Yu and Sambangi, Abhijeet and Swaminathan, Shreya and Pei, Zifei and Ji, Wenyu and Li, Zeru and Guo, Yaowei and Li, Zhifei and Chen, Gong},
title = {Brain‐Wide Neuroregenerative Gene Therapy Improves Cognition in a Mouse Model of Alzheimer's Disease},
journal = {Advanced Science},
year = {2025},
volume = {12},
number = {14},
doi = {10.1002/advs.202410080}
}
EUVIMED